By analyzing the genetic alterations in diffuse low‐grade gliomas, Aoki et al. found that altered RB pathway genes including CDKN2A and CDK4 could be independent predictors of poor survival in IDH-mutant astrocytomas [9]. Here, RB1 is linked to astrocytoma (excluding glioblastoma).